Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; Back to Top link removed.
    Difference
    0.3%
    Check dated 2025-09-13T17:37:17.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T15:01:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new drug information and related topics, while removing some previous drug details and location information. Notably, the facility name and location have been added, enhancing the core content.
    Difference
    6%
    Check dated 2025-08-30T11:49:38.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:34:47.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The webpage has been updated with new results regarding Progression Free Survival (PFS) and Overall Survival (OS) metrics, including specific reporting dates and study documentation from Hitendra Patel at UC San Diego.
    Difference
    9%
    Check dated 2025-08-08T23:49:56.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-01T19:21:12.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.